Campto ® 40 mg/2 ml Solution

    Campto ® 40 mg/2 ml Solution

    S4

    API: Irinotecan | Company: Pfizer

    1. What CAMPTO is and what it is used for.

    CAMPTO is used to treat colorectal cancer.

    2. What you need to know before you take/use CAMPTO.

    You should not be administered CAMPTO:

    • If you are hypersensitive (allergic) to irinotecan hydrochloride trihydrate or any of the other ingredients of CAMPTO.
    • If you are pregnant or breastfeeding.
    • If you have severe bone marrow failure.
    • If your WHO performance status > 2 (i.e. if your general health status does not allow you to carry out general activities of daily living).
    • If you have a disease involving frequent inflammation of the intestine (chronic inflammatory bowel disease) or blockage of the intestine (ileus).
    • If your bilirubin (breakdown product of red blood cells) level is high.
    • If you are a child.
    • If you are taking azole antifungal medication (used to treat fungal infections) or St John’s Wort (a herbal supplement).

    Tell your doctor or healthcare professional before being given CAMPTO if:

    • you have impaired liver function you are at greater risk of developing severe decrease in white blood cells or fever.
    • you experience nausea and vomiting. If you experience vomiting together with delayed diarrhoea, you should be hospitalised for treatment.
    • you experience early diarrhoea together with a group of symptoms such as sweating, abdominal cramping, watery eyes and salivation. If this occurs, inform your doctor as a specific medication is required in order for these symptoms to disappear.
    • you are an elderly patient, the dose may have to be adjusted accordingly.

    Contraceptive measures must be taken during and for at least 3 months after stopping therapy.

    Avoid vaccination with live vaccines. CAMPTO should only be administered under the supervision of a qualified medical doctor in units specialised in the administration of chemotherapy. It is recommended that CAMPTO be administered only in healthcare institutions with adequately equipped facilities, including an intensive care unit.

    3. How to take/use CAMPTO.

    CAMPTO is an injection. You will not be expected to give yourself CAMPTO. It will be given to you by a person who is qualified to do so.

    If you receive more CAMPTO than you should:

    Since a healthcare professional will administer CAMPTO, he/she will control the dosage. However in the event of overdosage, your doctor will manage the overdosage.

    If you miss a dose of CAMPTO:

    Do not receive a double dose to make up for forgotten individual doses.

    4. Possible side effects.

    CAMPTO can have side effects. Not all side effects reported for CAMPTO are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking CAMPTO please consult your doctor, pharmacist or other health care professional for advice.

    The following conditions have been reported with the use of CAMPTO:

    • severe allergic reactions
    • perforation in the intestine
    • kidney impairment or failure

    These are very serious side effects. You may need urgent medical attention or hospitalisation.

    Diarrhoea

    CAMPTO may cause you to have diarrhoea. There are two types of diarrhoea, which can be distinguished by when they start. “Early” diarrhoea starts less than 24 hours after the infusion and “delayed” diarrhoea starts more than 24 hours after the infusion. If you have ANY DIARRHOEA it is IMPORTANT that you tell your doctor or healthcare professional immediately.

    Patients with an increased risk of diarrhoea are those who had a previous abdominal/pelvic radiotherapy and initial raised white blood cells.

    Early diarrhoea (Frequent)

    • if your diarrhoea starts less than 24 hours after the infusion (“early diarrhoea”) you should contact your doctor IMMEDIATELY. This “early diarrhoea” may be accompanied by a group of other symptoms listed below. This is known as acute cholinergic syndrome occurring during or within the first 24 hours after the infusion of CAMPTO. The symptoms may be:

    • abdominal pain/cramping

    Less frequent:

    • chills
    • lacrimation (watery eyes)
    • rhinitis (irritation and inflammation inside the nose which may result in stuffy nose, runny nose and/or post-nasal drip)
    • dizziness
    • hypotension (low blood pressure)
    • malaise (lack of well being)
    • increased salivation (mouth watering)
    • myosis (constriction to the pupil of the eyes)

    Frequency unknown:

    • sweating
    • visual disturbances
    • conjunctivitis (inflammation of the eye)
    • vasodilation (widening of blood vessels)

    Delayed diarrhoea (Frequent)

    • if your diarrhoea starts more than 24 hours after the infusion (“delayed diarrhoea”) you should IMMEDIATELY contact your doctor.

    You must tell your doctor if:

    • you have nausea and vomiting as well as diarrhoea
    • you have any fever as well as the diarrhoea
    • you still have diarrhoea 48 hours after starting the diarrhoea treatment

    Do not take any treatment for diarrhoea other than that given to you by your doctor.

    Decrease in white blood cells (Frequent)

    CAMPTO may cause a decrease in the number of some of your white blood cells, which play an important role in fighting infections. This is called neutropenia. If you have any fever this may be an indication of infection associated with this neutropenia.

    Nausea and vomiting (Frequent)

    If you have any fever, and particularly if you also have diarrhoea and/or nausea and/or vomiting contact your doctor IMMEDIATELY.

    Other side effects

    If you experience any of the following conditions please report it to a doctor IMMEDIATELY:

    • difficulty in breathing
    • dehydration
    • change in kidney function tests
    • excessive bilirubin (breakdown product of red blood cells) in the blood
    • low blood volume resulting in dizziness or fainting
    • inflammation and ulceration of the membranes lining the digestive tract
    • infection
    • anaemia which is decreased number of red blood cells which may lead to a feeling of weakness, fatigue or poor concentration
    • leucopenia which is too few white blood cells which results in greater risk of infection
    • thrombocytopenia which is too few platelets in the blood which may result in bleeding into the skin, bruising or prolonged bleeding after injury
    • blockage of blood vessels that can result in severe chest pain, stroke, inflammation of a vein with formation of a clot, heart attack, heart arrest, sudden death

    Other side effects which may occur when you are treated with CAMPTO are:

    • loss of hair
    • lack of appetite
    • constipation
    • inflammation of the mouth
    • decreased weight
    • pain
    • lack of energy

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    5. How to store CAMPTO.

    Store all medicines out of reach of children.

    Single-dose vials of CAMPTO solution for infusion should be stored at or below 25 °C and protected from light. The product must be kept in the carton until required for use.

    CAMPTO 40 mg/2 ml and Campto 100 mg/5 ml: After dilution in either 0,9 % sodium chloride or 5 % dextrose, the diluted solution is stable for 24 hours at a temperature at or below 25 ºC or 4 days under refrigeration (between 2 and 8 ºC). Discard any unused portion thereafter.

    CAMPTO CSV 300 mg/15 ml: After dilution in either 0,9 % sodium chloride or 5 % dextrose, the diluted solution is stable for 24 hours under refrigeration (between 2 and 8 ºC). Discard any unused portion.

    Do not freeze. Do not use CAMPTO after the expiry date which is printed on the label. Return all unused medicines to your pharmacist. Do not dispose of unused medicines in drains or sewerage systems (e.g. toilets).

    Important Disclaimer

    The Campto ® 40 mg/2 ml Solution professional information leaflet below is the property of Pfizer and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Campto ® 40 mg/2 ml Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites